Product Images Hydrocodone Bitartrate

The text describes a table showing the percentage of subjects. There is also a title indicating a percent reduction in Emax of a drug for manipulated hydrocodone bitartrate extended-release tablets compared to powdered hydrocodone when administered intranasally.*

This appears to be a graph or table showing the percentage of subjects and their corresponding reduction in Emax of drug liking for chewed hydrocodone bitartrate extended-release tablets versus hydrocodone solution following oral administration. The x-axis shows values ranging from ">0" to "2100" while the y-axis shows the percentage of subjects. Unfortunately, without more context or a visual representation of the graph/table, it is difficult to provide more information or interpretation.*

This text is a medication label for Hydrocodone Bitartrate extended-release tablets with a dosage of 100mg per tablet. The tablets should be stored in a tight, light-resistant container at room temperature (between 15°C to 30°C). The patient must be provided with a medication guide, and the tablets should be swallowed whole without cutting, breaking, chewing, crushing or dissolving. The manufacturer of the medication is Alvogen, Inc, and the product is made in the USA.*

This is a medication guide and prescription drug information for NDC 47781-398-60, an extended-release tablet containing 120mg of Hydrocodone Bitartrate. The tablets should be dispensed in a tight, light-resistant container and stored at a room temperature of 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication guide must be provided to the patient along with the drug upon dispensing, and the tablets should not be cut, broken, chewed, crushed or dissolved. The product is distributed by Alvogen, Inc. and is for prescription-only use.*

NDC 47781-392-60 is a medication containing 20mg of Hydrocodone Bitartrate. It is an extended-release tablet that should be dispensed in a tightly sealed, light-resistant container. It is advised to store the medication at room temperature (between 15-30°C, 59-86°F). The accompanying medication guide must be provided to the patient upon dispensing. The tablets must be swallowed whole and should not be crushed, cut, or dissolved. This medication is distributed by Alvogen, Inc. in the USA. The prescribing information should be read before taking this medication.*

This text provides dosage information for NDC 47781-393-60 tablets containing 30mg of hydrocodone bitartrate, and advises to store in a light-resistant container at room temperature. The medication guide must also be provided to the patient when dispensing. The tablets should be swallowed whole and not cut, chewed, or dissolved. It is distributed by Alvogen, Inc in the USA.*

This is a description for a medication with the NDC code 47781-394-60. It is an extended-release tablet containing Hydrocodone Bitartrate, USP, with a strength of 40 mg. The medication guide must be provided to the patient upon dispensing. The tablet should be swallowed whole and stored in a tight, light-resistant container at room temperature. The medication is distributed in the USA by Alvogen, Inc. There is no indication for the medical condition being treated or the recommended frequency of intake.*

This is a medication with National Drug Code (NDC) 47781-395-60 and its usual dosage is not available. The medication contains Hydrocodone Bitartrate and should be dispensed in a light-resistant container. It should be stored at room temperature between 15 to 30°C (59° to 86°F). A medication guide must be provided to the patient upon dispensing. The tablets must be swallowed whole and not cut, broken, chewed, crushed, or dissolved. This medication is manufactured by Alvogen in the United States.*